JP2023512707A5 - - Google Patents

Info

Publication number
JP2023512707A5
JP2023512707A5 JP2022547802A JP2022547802A JP2023512707A5 JP 2023512707 A5 JP2023512707 A5 JP 2023512707A5 JP 2022547802 A JP2022547802 A JP 2022547802A JP 2022547802 A JP2022547802 A JP 2022547802A JP 2023512707 A5 JP2023512707 A5 JP 2023512707A5
Authority
JP
Japan
Prior art keywords
nucleic acid
nanoparticle
tumor
approximately
nanoparticles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022547802A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023512707A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/016925 external-priority patent/WO2021158996A1/en
Publication of JP2023512707A publication Critical patent/JP2023512707A/ja
Publication of JP2023512707A5 publication Critical patent/JP2023512707A5/ja
Pending legal-status Critical Current

Links

JP2022547802A 2020-02-05 2021-02-05 Ｒｎａ負荷ナノ粒子およびがんの治療のためのそれらの使用 Pending JP2023512707A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202062970646P 2020-02-05 2020-02-05
US62/970,646 2020-02-05
US202062991404P 2020-03-18 2020-03-18
US62/991,404 2020-03-18
PCT/US2021/016925 WO2021158996A1 (en) 2020-02-05 2021-02-05 Rna-loaded nanoparticles and use thereof for the treatment of cancer

Publications (2)

Publication Number Publication Date
JP2023512707A JP2023512707A (ja) 2023-03-28
JP2023512707A5 true JP2023512707A5 (https=) 2024-02-13

Family

ID=77200411

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022547802A Pending JP2023512707A (ja) 2020-02-05 2021-02-05 Ｒｎａ負荷ナノ粒子およびがんの治療のためのそれらの使用

Country Status (4)

Country Link
US (1) US20230096704A1 (https=)
EP (1) EP4099988A4 (https=)
JP (1) JP2023512707A (https=)
WO (1) WO2021158996A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7783628B2 (ja) * 2019-07-19 2025-12-10 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 多層ｒｎａナノ粒子
US20240238418A1 (en) 2021-05-07 2024-07-18 University Of Florida Research Foundation, Inc. Car t cell therapy method
CN113876691B (zh) * 2021-09-26 2023-08-08 华中科技大学同济医学院附属协和医院 一种包载靶标lncRNA Pvt1纳米粒子的水凝胶及其制备方法和应用
WO2023196232A1 (en) * 2022-04-04 2023-10-12 University Of Florida Research Foundation, Inc. Method of characterizing tumors
WO2025207807A1 (en) * 2024-03-27 2025-10-02 The University Of Florida Research Foundation, Inc. Ctc rna-loaded nanoparticles and use thereof for the treatment of cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897269A (en) * 1984-09-24 1990-01-30 Mezei Associates Limited Administration of drugs with multiphase liposomal delivery system
IN190388B (https=) * 1997-10-01 2003-07-26 Biomira Usa Inc
WO2013143555A1 (en) * 2012-03-26 2013-10-03 Biontech Ag Rna formulation for immunotherapy
ITRM20120480A1 (it) * 2012-10-09 2014-04-10 Uni Degli Studi Camerino Nanoparticelle lipidiche multicomponenti e procedimenti per la loro preparazione.
CN107073028A (zh) * 2013-12-13 2017-08-18 南洋理工大学 多层纳米颗粒及其制作方法和使用方法
US20190351040A1 (en) * 2017-02-01 2019-11-21 Modernatx, Inc. Rna cancer vaccines
US20220233568A1 (en) * 2017-10-19 2022-07-28 Curevac Ag Novel artificial nucleic acid molecules
EP3790533A1 (en) * 2018-05-08 2021-03-17 University of Florida Research Foundation, Incorporated Magnetic liposomes and related treatment and imaging methods
SG11202110036RA (en) * 2019-03-19 2021-10-28 Arcturus Therapeutics Inc Method of making lipid-encapsulated rna nanoparticles

Similar Documents

Publication Publication Date Title
JP2023512707A5 (https=)
Zhang et al. Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
Takakura et al. Strategies for persistent retention of macromolecules and nanoparticles in the blood circulation
Hussen et al. Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy
Barba et al. Lipid delivery systems for nucleic-acid-based-drugs: From production to clinical applications
LI et al. Surface‐modified LPD nanoparticles for tumor targeting
Buyens et al. Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design
Huang et al. Nanoparticles-based strategies to improve the delivery of therapeutic small interfering RNA in precision oncology
Huang et al. Biomimetic cell membrane-coated nanocarriers for targeted siRNA delivery in cancer therapy
US9574210B2 (en) Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
Luo et al. Nanoplatform‐based in vivo gene delivery systems for cancer therapy
JP2023520506A5 (https=)
Campani et al. Lipid nanovectors to deliver RNA oligonucleotides in cancer
JP2011503070A (ja) 全身遺伝子送達のための自己構築型ミセル様ナノ粒子
Rahman et al. Nucleic acid-loaded lipid-polymer nanohybrids as novel nanotherapeutics in anticancer therapy
US10113151B2 (en) Composition of viral vectors in lecithin liposomes, preparation method and treatment methods
CN106667914B (zh) 靶向脂质体-环二核苷酸的组成、制备方法及其在抗肿瘤中的应用
JP2025138644A5 (https=)
Sokolov et al. Targeted drug delivery in lipid-like nanocages and extracellular vesicles
Soleimani et al. CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice
JP2023515927A5 (https=)
JP2022518479A5 (https=)
CN119074950A (zh) 一种增强mRNA-LNP组织靶向递送的方法
Magalhaes et al. RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers
Deng et al. Advances in mRNA nanomedicines for malignant brain tumor therapy